Претраживање
Приказ резултата 1-10 од 15
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: Seroprevalence and risk factors
(Elsevier Science Bv, Amsterdam, 2006)
Toxoplasmosis is a globally distributed zoonosis with a clinical impact in the unborn fetus and in the immunosuppressed individual. In Serbia, studies of risk factors for Toxoplasma gondii infection in humans have shown ...
Concentrations of IL-17 and autoantibodies in sera of patients with primary Sjogren's syndrome
(BMJ Publishing Group, London, 2007)
Incidence of anti-alfa fodrin antibodies in primary sjogren syndrome and its correlation with anti ro/SS-A and anti La/SS-B antibodies
(BMJ Publishing Group, London, 2006)
Training and capacity building in central and eastern Europe through the EuroFIR and CEE networks
(Elsevier Sci Ltd, Oxford, 2009)
Capacity building in food and nutrition aims to enhance knowledge and support infrastructural development in this field. International Network of Food Data Systems (INFOODS) was established on the basis of the recommendations ...
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
(Lippincott Williams & Wilkins, Philadelphia, 2000)
Developmental and differential changes of gene expression in erythroid progenitor cells.
(Amer Soc Hematology, Washington, 2005)
Combined endothelin and AII blockade reduces mean arterial pressure and fails to improve postischaemic acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2003)
Haemodynamic effects of no and vitamin C supplementation in SHR with acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2006)